Gyun Min Lee

Title: Gyun Min Lee: Innovator in Biopharmaceuticals

Introduction

Gyun Min Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative fusion proteins. With a total of 4 patents to his name, Lee continues to push the boundaries of scientific research and application.

Latest Patents

One of his latest patents is the Glycosylated VEGF decoy receptor fusion protein. This application describes an isolated nucleic acid molecule encoding a polypeptide capable of synchronously binding VEGF polypeptide and placenta growth factor (PIGF) polypeptide, comprising a nucleotide sequence encoding a VEGFR1 component. Another notable patent is the fusion protein capable of binding VEGF-A and TNF-alpha. This application details an isolated nucleic acid molecule encoding a polypeptide that can synchronously bind VEGF polypeptide and TNF polypeptide. It includes a nucleotide sequence encoding a TNFR2 component and VEGFR1 component operatively linked to a nucleotide sequence encoding a multimerizing component.

Career Highlights

Gyun Min Lee is affiliated with the Korea Advanced Institute of Science and Technology, where he conducts his research and development activities. His work focuses on creating innovative solutions in the biopharmaceutical sector, contributing to advancements in medical treatments.

Collaborations

Lee collaborates with esteemed colleagues such as Gou Young Koh and Ho Min Kim. Their combined expertise enhances the research and development efforts within their field.

Conclusion

Gyun Min Lee is a notable inventor whose work in biopharmaceuticals has led to significant advancements. His innovative patents and collaborations reflect his commitment to improving healthcare through scientific research.